ANGIE: Nanorobots could target cancers and clear blood clots

The EU-funded ANGIE project is moving forward with small-scale robotics, magnetic navigation systems and localised targeted drug delivery. Specifically, the project will develop magnetically steerable wireless nanodevices for the targeted delivery of therapeutic agents via the body's vascular system. By creating a baseline of knowledge and skills for localised targeted drug delivery, the project will increase health professionals' capacity to treat multiple chronic diseases. Moreover, it will enable doctors to deliver drugs precisely where needed with minimal side effects.

Professor Salvador Pané and Professor Josep Puigmartí-Luis, researchers in the ANGIE project, hope targeted drug delivery will allow doctors to treat a greater number of stroke patients more effectively.  With ANGIE, the researchers are creating tiny nanorobots that can deliver the drug directly onto a clot with great precision and control. 

Related

Nanorobots could target cancers and clear blood clots (Horizon magazine)

ANGIE project in the CORDIS database